News Wire

Newly released phase 3 results have shown that lanadelumab, Shire plc’s experimental hereditary angioedema (HAE) drug, reduced monthly attack rates and improved quality of life compared with placebo. Recently presented at the 2018 American Academy of Allergy, Asthma, and Immunology meeting, the data…
A federal judge in New York on Monday ordered Martin Shkreli, the former drug company executive convicted of defrauding investors, to forfeit $7.36 million in assets, which could include a Picasso painting and a one-of-a-kind album by the Wu-Tang Clan. U.S. District Judge Kiyo Matsumoto in Brooklyn…
The FDA’s bid to shut down an Arkansas drug compounder over allegations of “serious deficiencies” is drawing a heated response from the company owner, who says he’s fighting “a bureaucracy that makes broad claims against us, gives little feedback, and ignores independent third-party experts.”…
A first-in-class medication being developed to treat back-of-the-eye diseases achieved positive results in the pivotal phase 3 PEACHTREE trial, the developer has announced. Among patients with macular edema associated with noninfectious uveitis, 47% of those treated every 12 weeks with suprachoroidal…
The multiple sclerosis medication daclizumab (Zinbryta, Biogen/AbbVie) is being withdrawn from the market voluntarily following reports that it has been associated with inflammatory encephalitis and meningoencephalitis. The two companies said that “characterizing the complex and evolving benefit/risk…
Influenza activity decreased in the United States during the week ending February 24, according to the Centers for Disease Control and Prevention (CDC). In week 8 of this trying flu season, the proportion of outpatient visits to doctors blamed on influenza-like illness (ILI) fell for the third straight…
The FDA has approved a lidocaine topical system (ZTlido, Sorrento Therapeutics, Inc.), 1.8%, for the relief of pain associated with post-herpetic neuralgia (PHN) that Sorrento bills as “a major advancement in analgesics” because of improved adhesion. “ZTlido was designed to solve a problem that…
Nearly one in five health employees (18%) said they would be willing to sell confidential data to unauthorized parties, according to a new survey from consultant Accenture. The survey of 912 employees of provider and payer organizations in the United States and Canada found that the respondents willing…
Mylan N.V. and Revance Therapeutics, Inc., are teaming up to develop and market a biosimilar to Allergan’s Botox (onabotulinumtoxinA), the market-leading product in a neuromodulator market with overall sales estimated at $4 billion. The two companies announced a global collaboration and license agreement…
Drug-makers are racing to scoop up patient health records and strike deals with technology companies as big data analytics start to unlock a trove of information about how medicines perform in the real world, according to a Reuters report. Studying such real-world evidence (RWE) offers manufacturers…
Two new studies suggest that patients do better when providers switch from using intravenous saline therapy to balanced fluids that closely resemble the liquid part of blood. Vanderbilt University Medical Center researchers believe the studies could improve survival and decrease kidney complications.…
The National Comprehensive Cancer Network (NCCN) has released new NCCN Clinical Practice Guidelines in Oncology intended to help make sure people living with human immunodeficiency virus (HIV) infection who are diagnosed with cancer receive safe, necessary treatment. In 2010, an estimated 7,760 people…
Wilson’s disease patients had been champing at the bit for Teva Pharmaceuticals’ generic of Valeant Pharmaceuticals’ Syprine (trientine hydrochloride), which the company billed as a “lower-cost generic.” But after the drug launched this month, patients discovered Teva’s generic isn’t much…
The FDA has approved abemaciclib (Verzenio, Eli Lilly and Co.) in combination with an aromatase inhibitor (AI) as initial endocrine-based therapy for the treatment of postmenopausal women with hormone receptor-positive (HR+), human epidermal growth factor receptor 2-negative (HER2–) advanced or metastatic…
Survival from cardiac arrest doubled when a bystander stepped in to apply an automated external defibrillator (AED) before emergency responders arrived, according to new research in the American Heart Association (AHA) journal Circulation. According to the AHA, of the more than 350,000 out-of-hospital…

Pages